Dividends Calendar Earnings Calendar
NBIX

NBIX | Neurocrine Biosciences Inc

Healthcare sector
Neurocrine Biosciences Inc
Category: Consumer goods
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   San Diego, California, United States

Trade prices

  • Volume:
  • Market Cap: 9.49B
  • Prev closed:
  • Open:
  • High:
  • Low:
  • 52 week low:
  • 52 week high:
  • Dividends:No Dividends

Next ER: May 3, 2023  Before Market Opens



Top Stories (NBIX)

    About the Company

    Neurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 1, 2023
    May 3, 2023-0.51 / 0.63410M / 410.82M
    February 6, 20231.24 / 1.12412M / 408.87MBeat!
    November 1, 20221.08 / 0.8387.9M / 376.55MBeat!
    August 4, 2022-0.18 / 0.6194378.2M / 342.33MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 2, 2023 103.45 103.28
    104.57
    102.84
    		 849K -0.55%
    May 1, 2023 104.02 101.2
    104.2
    100.9
    		 743K 2.95%
    Apr 28, 2023 101.04 101.28
    101.49
    99.85
    		 940K -0.84%
    Apr 27, 2023 101.9 102.35
    102.65
    100.86
    		 463K -0.8%
    Apr 26, 2023 102.72 101.46
    102.96
    100.9
    		 471K 0.34%
    Apr 25, 2023 102.37 103.25
    103.82
    102.12
    		 622K -1.15%
    Apr 24, 2023 103.56 104.12
    104.16
    102.86
    		 489K -0.59%
    Apr 21, 2023 104.17 105
    105.22
    104.12
    		 514K -0.37%
    Apr 20, 2023 104.56 104.67
    104.79
    103.88
    		 513K -0.3%
    Apr 19, 2023 104.87 103.13
    105.02
    103.13
    		 590K 1.11%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:1992
    • Employees:700

    News

    News for (NBIX)

    This company doesn't provide a dividend.


    Talk about Neurocrine Biosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 3, 2023 (Same day)

    ctsh syna trip z el qcom sedg apa mos mur psx wmb 


    Jump to (Finance sites)

    Google   
             

    Research 


    Investor page

    www.neurocrine.com

    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 63
    HOLD 31
    SELL 6

    Their Official Profiles 

    WikipediaLinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.